Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00077935 · ClinicalTrials.gov registry record · Phase 3
Civamide in OA of the Knee(s)
A Phase 3 study of Osteoarthritis, Knee, sponsored by Winston Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 351
- Enrollment target
- 20
- Study locations
NCT00077935: Completed Phase 3 study of Osteoarthritis, Knee, sponsored by Winston Laboratories.
NCT00077935 is a Phase 3 study of Osteoarthritis, Knee that has completed, run by Winston Laboratories. The registered enrollment target is 351 participants, below the 495-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (29% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00077935, a Phase 3 study of Osteoarthritis, Knee, has completed, sponsored by Winston Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 351 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis (OA) of the Knee(s).
Conditions Studied
Interventions
- DRUG Civamide
Study Locations (20)
Florida
- Radiant Research - Daytona Beach
- University Clinical Research - DeLand
- Robert W. Levin, MD - Dunedin
- University Clinical Research Inc. - Pembroke Pines
California
- OMC Clinical Research Center - Beverly Hills
- Med. Investigations - Fair Oaks
- Boling Clinical Trials - Rancho Cucamonga
Missouri
- Center for Pharmaceutical Research - Kansas City
- Medex Healthcare Research Inc. - St Louis
Alabama
- Innovative Clinical Trials - Birmingham
Arizona
- University of Arizona - Tucson
Georgia
- Radiant Research - Atlanta
Idaho
- Radiant Research - Boise
Illinois
- Feinberg School of Medicine/Office of Clinical Rsrch and Trng - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 351 participants |
| Start Date | 2003-11 |
| Est. Completion | 2005-07 |
| Phase | Phase 3 |
What the finished NCT00077935 record still lists
NCT00077935 is an interventional study that assigns participants to a tested intervention. The registered 351 participants enrollment target is mid-sized for trials with a published cap, below the 495-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Civamide is the first listed.
NCT00077935 names 20 study sites across 14 states, led by Florida, California, Missouri.
Frequently Asked Questions
What is clinical trial NCT00077935 about?
NCT00077935 is a clinical study titled "Civamide in OA of the Knee(s)". The purpose of this study is to evaluate the safety of Civamide Cream 0.075% as a Treatment in Subjects with Osteoarthritis (OA) of the Knee(s).
What is the current status of trial NCT00077935?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 351 participants. The study started on 2003-11. Estimated completion is 2005-07.
What conditions does trial NCT00077935 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT00077935?
The interventions under investigation include: Civamide (DRUG).
Who is sponsoring clinical trial NCT00077935?
This trial is sponsored by Winston Laboratories, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00077935 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00077935's enrollment target sits among peer trials
351 24th of 112 higher than 89 of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
RECRUITING · Phase 3
-
Rehabilitation for Arthritis of The Knee: mainTaining Improvement for Veterans
RECRUITING · Phase 3
-
A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
ACTIVE NOT RECRUITING · Phase 3
-
Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight
ACTIVE NOT RECRUITING · Phase 3
-
Microfragmented Adipose Tissue Compared to Saline Injection for the Treatment of Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06241456 · 351 participants · Phase 1
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
- NCT06576726 · 351 participants
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
- NCT07043400 · 351 participants · Phase 3
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT07261423 · 351 participants · NA
Pollution Intervention to Impact Kids Asthma Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia